STOCK TITAN
  1. Home
  2. News
  3. GEHC

GE HealthCare Technologies Inc. - GEHC STOCK NEWS

Welcome to our dedicated page for GE HealthCare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on GE HealthCare Technologies stock.

GE HealthCare Technologies Inc. (NYSE: GEHC) is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions. The company operates through four main segments: Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Of these, the Imaging segment generates the majority of the company’s revenue.

GE HealthCare is dedicated to providing transformational medical technologies and services that enhance access to quality, affordable healthcare worldwide. Through its cutting-edge products and comprehensive solutions, the company aims to improve patient outcomes and streamline healthcare delivery.

Recent achievements include advancements in artificial intelligence (AI) integration within medical imaging, which supports more accurate and efficient diagnostics. The company is also involved in numerous partnerships with healthcare providers and research institutions to drive innovation and improve global healthcare standards.

Financially, GE HealthCare has showcased robust performance, with steady revenue growth and strong market presence. The company continuously invests in R&D to maintain its edge in the competitive healthcare industry. Their suite of products includes advanced imaging machines, ultrasound devices, patient monitoring systems, and contrast media for diagnostic imaging.

As part of a highly regulated industry, GE HealthCare adheres to strict compliance standards and maintains rigorous quality controls across its operations. The company actively engages with its community, although it reserves the right to monitor and manage public interactions to uphold professional and constructive discourse.

News

GE HealthCare Management to Present at 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary
GE HealthCare (GEHC) executives to attend 42nd Annual J.P. Morgan Healthcare Conference. President and CEO, Peter Arduini, and CFO, Jay Saccaro, will participate in a Q&A session on January 9th. The live webcast can be accessed on GE HealthCare's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
conferences
-
News

GE HealthCare Announces Cash Dividend for Fourth Quarter of 2023

Rhea-AI Summary
GE HealthCare Technologies Inc. (Nasdaq: GEHC) declares a cash dividend of $0.03 per share of Common Stock for the fourth quarter of 2023, payable on February 15, 2024, to all shareholders of record as of January 16, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.68%
Tags
dividends
-
News

Nantworks AirStrip® and GE HealthCare Announce Agreement to Commercialize Integrated Patient Monitoring and Cardiac Data Visualization for Healthcare Systems

Rhea-AI Summary
GE HealthCare (GEHC) and AirStrip announced a joint commercialization agreement, making GEHC the exclusive distributor of AirStrip Cardiology and Patient Monitoring solutions in the U.S. This collaboration provides healthcare systems with deeply integrated offerings and a comprehensive ecosystem of solutions to enhance patient care and outcomes. The partnership aims to support providers and clinical staff in enabling efficient workflow and patient monitoring in near real time across mobile devices and the web.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
none
News

GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023

Rhea-AI Summary
GE HealthCare (NASDAQ: GEHC) introduces True Enhance DL to its Effortless Recon DL portfolio, leveraging deep learning for CT imaging. The company aims to improve image quality and clinical decision-making for neurology, oncology, and cardiology to benefit patients globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
none
-
News

GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis

Rhea-AI Summary
GE HealthCare (GEHC) announces FDA 510K clearance for Critical Care Suite 2.1 with Pneumothorax (PTX) algorithm. The on-device AI detects and localizes PTX, reducing reporting times by 57% and increasing clinician detection of small PTXs by 17.7%. The algorithm has 100% partial localization accuracy for large PTXs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.23%
Tags
clinical trial
-
News

GE HealthCare Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection

Rhea-AI Summary
GE HealthCare (GEHC) introduces MyBreastAI Suite, an all-in-one AI platform for mammography, integrating three AI applications from iCAD to aid clinicians in breast cancer detection, breast density assessment, and notification. The platform aims to combat increasing challenges faced by radiologists and health systems, such as burnout, workforce attrition, and patient backlogs. MyBreastAI Suite will be available in the United States and will be distributed, installed, and supported by GE HealthCare as part of the company’s Senographe Pristina mammography portfolio.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.49%
Tags
none
News

GE HealthCare Showcases More Than 40 Innovations, Including AI-Enabled Imaging Technology Solutions Designed for Precision Care at RSNA23

Rhea-AI Summary
GE HealthCare (GEHC) will highlight over 40 innovations, including key AI-enabled technologies in Imaging, Ultrasound, and digital solutions at the RSNA 2023 Annual Meeting. The company aims to address radiologist shortages and burnout, and the challenges of an aging population by providing smart devices, streamlined disease state focus, and digital solutions to improve patient outcomes and operational efficiencies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
News

GE HealthCare Announces New Version of Digital Expert Access, the First FDA 510(k)-Cleared Device to Enable Remote Patient Scanning, and Exclusive Distribution Agreement with IONIC Health

Rhea-AI Summary
GE HealthCare (GEHC) has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access with remote scanning, a first-of-its-kind solution that enables remote patient scanning. The collaboration with IONIC Health aims to provide a multi-vendor, multi-modality remote scanning solution to healthcare systems globally, addressing the shortage of radiologists and operational efficiency challenges.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
none
-
News

University of Wisconsin–Madison and GE HealthCare Broaden Shared Commitment to Healthcare Innovation

Rhea-AI Summary
GE HealthCare (GE) and University of Wisconsin School of Medicine and Public Health (UW–Madison) announce a 10-year strategic collaboration to advance personalized healthcare. The collaboration expands beyond medical imaging to digital technologies and disease-focused solutions, leveraging UW–Madison's expertise and GE's medical technology modernization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
none
News

GE HealthCare to Hold Fireside Chat with Citi Medtech Analyst at RSNA 2023

Rhea-AI Summary
GE HealthCare (GEHC) to Hold Fireside Chat at RSNA 2023 Annual Meeting with CEO and CFO - Live Webcast Details and Access Information
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.14%
Tags
none

FAQ

What is the current stock price of GE HealthCare Technologies (GEHC)?

The current stock price of GE HealthCare Technologies (GEHC) is $82.44 as of November 22, 2024.

What is the market cap of GE HealthCare Technologies (GEHC)?

The market cap of GE HealthCare Technologies (GEHC) is approximately 36.9B.

What does GE HealthCare Technologies Inc. do?

GE HealthCare Technologies Inc. provides transformative medical technologies, pharmaceutical diagnostics, and digital solutions to improve healthcare access and quality globally.

What are the main business segments of GE HealthCare?

The main business segments are Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).

How does GE HealthCare generate most of its revenue?

The company generates the majority of its revenue from the Imaging segment.

What recent advancements has GE HealthCare made?

GE HealthCare has made significant advancements in AI integration within medical imaging, improving diagnostic accuracy and efficiency.

Who are GE HealthCare's partners?

The company collaborates with healthcare providers and research institutions to drive innovation and improve healthcare standards.

How does GE HealthCare ensure compliance?

GE HealthCare adheres to strict regulatory compliance standards and maintains rigorous quality controls across its operations.

What products does GE HealthCare offer?

GE HealthCare offers a range of products, including imaging machines, ultrasound devices, patient monitoring systems, and diagnostic contrast media.

What is GE HealthCare's commitment to the community?

The company engages actively with its community and strives to maintain professional and positive interactions while monitoring public posts and conversations.

How has GE HealthCare performed financially?

GE HealthCare has shown robust financial performance with steady revenue growth, supported by continuous investment in research and development.

What is GE HealthCare's mission?

GE HealthCare is committed to improving patient outcomes and making quality healthcare more accessible and affordable worldwide.

Stock GEHC logo
GE HealthCare Technologies Inc.

Nasdaq:GEHC

GEHC Rankings

#354 Ranked by Market Cap
#2112 Ranked by Dividends

GEHC Stock Data

36.94B
442.78M
3.09%
83.51%
1.81%
Health Information Services
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States of America
CHICAGO